Optics News

Editor’s note: This is a developing news story. Please check back soon for updates.

Self-reported visual difficulty had a limited ability to identify adults with objectively measured visual impairment, according to an analysis of data from a nationally representative sample of Medicare beneficiaries.

Among children, errors of refraction and strabismic amblyopia were the most common causes of low vision, with retinal diseases most often causing severe vision loss, according to a study.

Myopes may undergo about –1 D of progression between the ages of 20 and 50 years, according to an analysis of three large studies published in Investigative Ophthalmology & Visual Science.

Hormonal changes can cause physiological and pathological changes in the eye, and eye care providers should monitor pregnant patients well past delivery, according to a literature review published in Clinical and Experimental Optometry.

Korean adults with stable myopic normal-tension glaucoma who had not received IOP-lowering treatment for at least 1 year were at increased risk for progression, according to a study published in Journal of Glaucoma.

Orasis Pharmaceuticals is announcing the U.S. launch of Qlosi at SECO 2025 in Atlanta.

Scleral lenses demonstrated safety and efficacy for treating ocular surface disease and irregular cornea/refractive conditions in children, according to an approximately 2-decade long study published in Clinical Optometry.

ORLANDO — In this Healio Video Perspective from Vision Expo East, Yair Yahav, CEO and founder of RevitalVision, discusses the U.S. launch of the company’s neurological therapy indicated to improve vision outcomes across various conditions.